Management of Infiltration Injury in Neonates Using DuoDerm Hydroactive Gel

Neonates are at increased risk of injury from infiltration of intravenous fluids because of small vessel size and immature skin structure. Until recently, hyaluronidase injection was used to prevent tissue injury following the infiltration of intravenous solutions in neonates. The production of hyaluronidase injection was discontinued in 2001. The alternative, compounded hyaluronidase injection is not regulated by the U.S. Food and Drug Administration and is subject to variation in quality assurance practices. Amorphous hydrogels have been used as wound dressings for sloughy or necrotic wounds in a variety of clinical settings. Hydrogels facilitate autodebridement of the wound by rehydrating slough and enhancing the rate of autolysis. No adverse effects or increased infection rates have been associated with the use of hydrogel dressings. DuoDerm Hydroactive gel is a sterile, preservative-free, viscous, hydrating gel composed of natural hydrocolloids. We report our experience using DuoDerm Hydroactive gel for management of injury secondary to the infiltration of total parenteral nutrition solution and lipid emulsion in three neonates.

KEYWORDS

Infiltration - hydrogel - neonates

REFERENCES

• 1 Evans N, Rutter N. Development of the epidermis in the newborn.  Biol Neonate. 1986;  49 74-80
• 2 Collinge J M, Aranda J VA. Nonmetabolic complications of neonatal intravenous therapy: epidemiologic considerations.  Am J Perinatol. 1984;  1 185-189
• 3 Van Reempts P, Van Overmeire B. Topical use of nitroglycerin in neonates.  J Pediatr. 1990;  116 155
• 4 Gault D T. Extravasation Injuries.  Br J Plast Surg. 1993;  46 91-96
• 5 Laurie S W, Wilson K L, Kernahan D A et al.. Intravenous extravasation injuries: the effectiveness of hyaluronidase in their treatment.  Ann Plast Surg. 1984;  13 191-194
• 6 Flemmer L, Chan J S. A pediatric protocol for management of extravasation injuries.  Pediatr Nurs. 1993;  19 355-358
• 7 Pediatric Pharmacy Advocacy Group (PPAG) . Position statement on hyaluronidase injection (Wyadase) availability.  JPPT. 2001;  6 522-524
• 8 Bey D, El-Chaar G M, Bierman F, Valderrama E. The use of phentolamine in the prevention of dopamine-induced tissue extravasation.  J Crit Care. 1998;  13 13-20
• 9 Nopper A J. Topical ointment therapy benefits premature infants.  J Pediatr. 1996;  128 660-669
• 10 O'Reilly C, McKay F MA, Duffty P, Lloyd D J. Glyceryl nitrate in skin necrosis caused by extravasation of parenteral nutrition.  Lancet. 1988;  2 565-566
• 11 Thomas S, Rowe H N, Keats J, Morgan R JH. A new approach to the management of extravasation injury in neonate.  Pharm J. 1987;  239 584-585
• 12 Eisenberg M. The effect of occlusive dressings on re-epithelizations of wounds in children with epidermolysis bulbosa.  J Pediatr Surg. 1986;  21 892-894
• 13 Prendiville J S, Herbert A A, Greenwald M J, Esterly N B. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.  J Pediatr. 1989;  115 881-887
• 14 Feldman D L, Rogers A, Karpinski R H. A prospective trial comparing Biobrane, Duoderm, and xeroform for skin graft donor sites.  Surg Gynecol Obstet. 1991;  173 1-5
• 15 Field F K, Kerstein M D. Overview of wound healing in a moist environment.  Am J Surg. 1994;  167 2S-6S
• 16 DuoDerm Hydroactive Gel Product Information. Princeton, NJ; Convatec, E.R. Squibb & Sons, Inc 1999
• 17 Zenk K E, Dungy C I, Greene G R. Nafcillin extravasation injury. Use of hyaluronidase as an antidote.  Am J Dis Child. 1981;  135 1113-1114
• 18 Banta C. Hyaluronidase.  Neonatal Netw. 1992;  11 103-105
• 19 Chandavasu O, Garrow E, Valda V, Alsheikh S, Dela Vega S. A new method for the prevention of skin sloughs and necrosis secondary to intravenous infiltration.  Am J Perinatol. 1986;  3 4-5
• 20 Falcone P A, Barrall D T, Jeyarajah D R, Grossman J A. Nonoperative management of full-thickness intravenous extravasation injuries in premature neonates using enzymatic debridement.  Ann Plast Surg. 1989;  22 146-149